The placenta is responsible for all nutrient and gas exchange between mother and baby during pregnancy. The differentiation of specialised placental epithelial cells called trophoblasts is essential for placental function, but we understand little about how these populations arise. Mouse trophoblast stem cells have allowed us to understand many of the factors that regulate murine trophoblast lineage development, but the human placenta is anatomically very different from the mouse, and it is imperative to isolate a human trophoblast stem cell to understand human placental development. Here we have developed a novel methodology to isolate a Hoechst side-population of trophoblasts from early gestation placentae and compared their transcriptome to differentiated trophoblast populations (cytotrophoblasts and extravillous trophoblasts) using microarray technology. Side-population trophoblasts clustered as a transcriptomically distinct population but were more closely related to cytotrophoblasts than extravillous trophoblasts. Side-population trophoblasts up-regulated a number of genes characteristic of trophectoderm and murine trophoblast stem cells in comparison to cytotrophoblasts or extravillous trophoblasts and could be distinguished from both of these more mature populations by a unique set of 22 up-regulated genes, which were enriched for morphogenesis and organ development and the regulation of growth functions. Cells expressing two of these genes (LAMA2 and COL6A3) were distributed throughout the cytotrophoblast layer at the trophoblast/ mesenchymal interface. Comparisons to previously published trophoblast progenitor populations suggest that the side-population trophoblasts isolated in this work are a novel human trophoblast population. Future work will determine whether these cells exhibit functional progenitor/stem cell attributes. Reproduction (2015) 150 449-462 
Introduction
The placenta is a fetal organ that forms the interface between the mother and baby. Trophoblasts, specialised epithelial cells only found in the placenta, play a key role in nutrient and gas exchange between mother and baby, and thus the regulation of trophoblast differentiation during placental organogenesis is crucial for fetal growth and health in utero.
In human embryos, the first differentiation step is the separation of the inner cell mass, which forms the embryo, and the trophectoderm from which all trophoblast lineages in the placenta arise. By 5 weeks of gestation, the villous placenta is characterised by a core of mesenchymal tissue containing fetal blood vessels, surrounded by a bi-layer of trophoblast comprising an inner layer of mononuclear villous cytotrophoblast, overlain by a multinucleated syncytiotrophoblast layer that covers the entire placenta and is in direct contact with the maternal blood. The syncytiotrophoblast is responsible for the exchange of nutrients and gasses between the maternal and fetal circulations and is also the major barrier separating the immunologically disparate maternal and fetal organisms. A third trophoblast population, extravillous trophoblasts, grow out from the tips of placental villi and invade the decidua, where they play a crucial role in adapting the uterine blood supply to support pregnancy.
Villous cytotrophoblasts were traditionally thought of as 'stem-like cells' with the ability to generate both extravillous trophoblasts and the syncytiotrophoblast. However, when cultured, isolated villous cytotrophoblasts (even from early gestation placentae) differentiate to form the multinucleated syncytiotrophoblast (Dodeur et al. 1990 ). Furthermore, work by ourselves and others has suggested that rather than existing as one homogenous bipotent population, cytotrophoblast subpopulations are primed to differentiate into either syncytiotrophoblast or extravillous trophoblast (Aboagye-Mathiesen et al. 1996 , James et al. 2005 , 2007 , Telugu et al. 2013 . Indeed, many epithelial stem cell populations have the ability to generate committed progenitors, referred to as transit amplifying cells, which are able to expand the progenitor pool in tissues with rapid growth or high turnover (Blanpain et al. 2007 ). In the placenta, it is likely that villous cytotrophoblasts represent this transit amplifying population and that a separate population of true trophoblast stem cells from which villous cytotrophoblasts arise also reside in placental villi.
At present we have a poor understanding of early cell lineage differentiation in the human placenta due to its relatively unique anatomy within the animal kingdom and the ethical issues involved in studying very early human placentae. The isolation of mouse trophoblast stem cells from the outer trophectoderm layer of murine blastocysts has allowed mouse trophoblast lineage differentiation to be almost completely mapped from blastocyst to functional placenta (Tanaka et al. 1998 , Senner & Hemberger 2010 . However, no suitable model exists to test whether findings in the mouse are relevant to human placentae. Therefore, it is imperative to develop a human trophoblast stem cell model to understand how the human trophoblast lineages develop. Therefore, the objective of this work was to isolate a Hoechst sidepopulation of trophoblasts from first trimester human placentae and undertake the molecular characterisation of this population to evaluate its potential as a human trophoblast stem cell population.
Methods
First trimester placental tissue was obtained with written informed consent from Auckland Medical Aid Centre (AMAC), Auckland. This was approved by the Northern Regional X Ethics Committee, Auckland, New Zealand (NTX/06/04/035).
Isolation of a Hoechst side-population from first trimester villi
First trimester villous tissue (5.6-12.0 weeks gestation) was washed in PBS (pH 7.4) to remove all maternal blood. Villi were dissected from the membranes, transferred to 25 ml tubes (LabServ, Auckland, New Zealand) and incubated with 10 ml 0.25% trypsin (Gibco, Auckland, New Zealand) containing 200 mg/ml DNAse I (Sigma) in PBS per gram of tissue in a 37 8C waterbath for 10 min (first trypsin digest). Villi were then gently mixed, 10 ml PBS was added and villi were allowed to settle to the bottom of the tube. Supernatant was removed and villi were washed eight times with 20 ml PBS to remove the extravillous trophoblasts and much of the syncytiotrophoblast layer, which was discarded. Next, 10 ml 0.25% trypsin containing 200 mg/ml DNAse I in PBS per gram of tissue was added and villi were incubated on a rocker at 4 8C for 7 min, then left stationary at 4 8C for 16 h (second trypsin digest). Villi were then washed ten times in PBS and washes were collected through 70 mm cell strainers into 50 ml tubes (Becton Dickinson, Auckland, New Zealand) containing 5 ml fetal bovine serum (FBS). Tubes were centrifuged at 450 g for 8 min, and supernatants were aspirated. Cell pellets were combined into 15 ml DMEM/F12 (Life Technologies) containing 5% FBS and incubated in a 10 cm petri dish in a humidified 37 8C environment with 5% CO 2 for 10 min to deplete contaminating fibroblasts by plastic adhesion. The cell suspension was removed, and the dish gently washed twice with 5 ml DMEM/F12 containing 5% FBS. The total cell suspension (25 ml) was divided into two universal tubes containing 20 and 5 ml each and centrifuged at 450 g for 8 min. In some experiments, cells were then incubated with 4.5 mg/ml of AlexaFluor647-conjugated anti-human HLA-A,B,C antibody (Clone W6/32, #311414, Biolegend, San Diego, CA, USA) in DMEM/F12 containing 5% FBS for 30 min prior to Hoechst staining. Supernatants were removed, pellets were resuspended, and 4 ml DMEM/F12 containing 5% FBS and 10 mg/ml Hoechst 33342 (Sigma-Aldrich) pre-warmed and pre-gassed in a 5% CO 2 environment was added to the larger pellet. For a negative control, 50 mM verapamil hydrochloride (Sigma-Aldrich) was added to the tube of the smaller pellet. Tubes were incubated in a 37 8C waterbath for 90 min, then centrifuged at 450 g for 8 min at 4 8C, supernatants were discarded and 2 ml ice cold PBS containing 1 mg/ml propidium iodide (PI) (Invitrogen) was added for 5 min at 4 8C. Tubes were washed with 20 ml ice cold PBS and then centrifuged at 450 g for 8 min at 4 8C. This wash step was repeated twice, then 2-3 ml ice-cold PBS was added to the main cell pellet and 0.5 ml ice-cold PBS was added to the verapamil hydrochloride control tube, and cell suspensions were transferred to sterile FACS tubes (Becton Dickinson) on ice. Cells were sorted on a Becton Dickinson Aria II SORP with the sample maintained at 4 8C. A 100 mm nozzle with 20 psi sheath pressure and sterile PBS as the sheath fluid was found to improve survival of the sorted cells. Some samples were sorted with an 85 mm nozzle and 45 psi sheath pressure. Dead cells were excluded based on PI staining (552 nm excitation with a Coherent Sapphire laser at 70 mW and emission detection with 600 LPand 610/20 BP filters). Doublets were excluded by gates on side scatter area vs height and forward scatter area vs height dot plots, and the single live cells were displayed on a Hoechst Red (635 LP and 670/50 BP filters) vs Hoechst Blue (450/50 BP) dot plot with linear scales. Hoechst 33342 cells were excited with a Coherent Genesis 355 nm 20 mW laser. The gate for side-population cells was determined by comparing the sample with the verapamil hydrochloride-treated control. Cells were sorted into tubes or plates with the standard purity precision mode (32/32/0) at a rate that maintained 90% efficiency or better, usually around 3000-5000 events/s. containing 100 ml of DMEM/F12 containing 5% FBS, 1% penicillin-streptomycin and 1% glutamax (Sigma) and allowed to adhere for 2 h in a humidified 5% CO 2 environment at 37 8C. Media were removed and cells were fixed with 100 ml of methanol for 10 min. Cells were washed twice with PBS and blocked with the addition of 10% normal goat serum (NGS) in PBS containing 0.05% Tween (PBS-Tween) for 10 min. Next, 100 ml of primary antibody (3.1 mg/ml vimentin (M072529, Dako, Glostrup, Denmark), HLA-G (5 mg/ml, AB7758, Abcam, Cambridge, UK) or W6/32 (ATCC clone HB-95, produced in this laboratory) or irrelevant IgG1 control antibody (Life Technologies) diluted in 10% NGS in PBS-Tween was added for 1 h at room temperature. Wells were washed twice in PBS-Tween, and a biotinylated anti-mouse IgG antibody (Jackson Immunoresearch, West Grove, PA, USA) diluted in 10% NGS in PBS-Tween was added for 1 h at room temperature. Wells were washed twice with PBS-Tween, and 100 ml of streptavidin-488 (Invitrogen) diluted in PBS-Tween was added to the wells for 1 h at room temperature. Wells were washed two more times, and 2 mg/ml anti-cytokeratin 7 antibody conjugated to eFluor615 (EBI-42-9005-82, eBioscience, San Diego, CA, USA) was added for 1 h at room temperature in the dark. In other experiments, antibodies raised against IL1R2 (1.25 mg/ml, MAB263, Pharmaco, Auckland, New Zealand) were added first, followed by a biotinylated mouse anti-human IgG antibody and streptavidin-PE (Invitrogen), then cells or slides were incubated with antibodies raised against IL7R (CD127) directly conjugated to FITC (1:20, 351312, Biolegend, San Diego, CA, USA). Cells were counterstained with 10 mg/ml Hoechst 33342 diluted in PBS for 5 min, washed twice with PBS and visualised on a Nikon Eclipse Ti inverted microscope (Nikon, Japan). When staining was quantified, five images (centre top, centre left, centre right, centre bottom and centre of the well) were captured for each well and the percentage of stained cells was quantified relative to Hoechst stained nuclei by digital image analysis (Image J, Bethesda, MD, USA). All experiments were repeated on cells isolated from at least three placentae.
Transcriptomic comparison of extravillous trophoblasts, cytotrophoblasts and side-population trophoblasts
To analyse different populations of trophoblasts isolated from the same placentae, the Hoechst side-population protocol was modified to allow immunofluorescent labelling of extravillous trophoblasts and villous cytotrophoblasts. Cells from the first trypsin digest were collected through 70 mM cell strainers into 50 ml tubes containing 5 ml FBS, then centrifuged at 450 g for 8 min. The cell pellet was resuspended and 90% of the cells were incubated for 30 min at 37 8C with 5 mg/ml of FITC-conjugated antibodies raised against HLA-G (AB7904, Abcam, Cambridge, UK) in DMEM/F12 containing 5% FBS, while the remaining 10% was incubated with DMEM/F12 containing 5% FBS only (negative control). Cells were centrifuged at 450 g for 8 min, stained with PI and washed with PBS as described above. FITC-positive cells were sorted using a Becton Dickinson Aria II SORP. Dead cells and doublets were excluded as described above. FITC detection was performed by 488 nm excitation with 505 LP and 530/30 BP emission filters.
Cells from the second overnight trypsin digest were collected as described and incubated for 30 min at 37 8C with 10 mg/ml of FITC-conjugated antibodies raised against b4 integrin (AB22486, Abcam) in DMEM/F12 containing 5% FBS, then stained with Hoechst 33342 and PI as described above. Ten percent of the cells from the second trypsin digest was incubated with DMEM/F12 containing 5% FBS only, then incubated with Hoechst 33342 and verapamil hydrochloride as a negative control. Dead cells, doublets and side-population cells were detected as described above. FITC was detected by 488 nm excitation and 505 LP and 530/30 BP emission filters.
All cells were sorted into 2 ml RNAse free tubes containing 0.5 ml RNALater (Life Technologies). RNA was extracted using the Invitrogen PureLink mini-kit (Life Technologies) according to the manufacturer's instructions. RNA quality and quantity was assessed using Experion RNA HighSens chips (Bio-Rad) according to the manufacturer's instructions. RNA was converted to cDNA and amplified using a NuGEN Ovation Pico WTA system V2 kit according to the manufacturer's instructions (NuGEN, San Carlos, CA, USA). Purified cDNA was biotin labelled and hybridised to Affymetrix PrimeView microarrays (Affymetrix, Santa Clara, CA, USA).
Microarray data were quality checked and found to be of good quality and free from obvious outliers. Data were Robust Multiarray Average (RMA) normalised following background correction and log transformation. The limma package in the statistical language R was used to assess the evidence for differential abundance of all RNA transcripts between each of the three groups (extravillous trophoblasts, cytotrophoblasts and Hoechst side-population trophoblasts). A blocked analysis was performed to correct for within-patient variance. Benjamini-Hochberg false-discovery rate (FDR) control was used to adjust P values for differential expression. A coefficient of 1.2 (corresponding to a 2.29-fold change) with corrected P values !0.05 were used as a cut-off to identify genes that were significantly different between populations. These data have been deposited in the Gene Expression Omnibus (GEO) database with accession number GSE57834.
To obtain transcriptomic profiles of previously isolated trophoblast progenitor cells (TBPC) and human embryonic stem cells (hESC) (Genbacev et al. 2011) , Affymetrix CEL files were obtained from the National Center for Biotechnology Information's (NCBI) GEO (reference GSE30127). These data were reanalysed using the process described above to obtain a directly comparable set of profiles between the two experiments; in addition, lists of differentially expressed transcripts from this analysis were checked against the analysis in the original publication and found to be in agreement.
Homeobox gene arrays
Human HOX gene, a TaqMan based cDNA array (Life Technologies) for gene profiling, was used to screen for HOX genes that showed differential expression in extravillous trophoblasts, cytotrophoblasts and Hoechst side-population cells. Briefly, cDNA was prepared and added to a Universal Mastermix (Life Technologies) and distributed in a cDNA array 96-well plate at w3 ng/well in a 20 ml reaction. The array plate contained 92 gene-specific primer sets for homeobox genes with a panel of four housekeeping gene primers for normalisation. These housekeeping genes consisted of 18S ribosomal RNA (18S), hypoxanthine phosphoribosyltansferase 1 (HPRT1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and b-actin (ACTB). The PCR was performed in an ABI Prism 7500 Sequence Detector (Life Technologies) under the following cycling parameters: 95 8C for 10 min, followed by 40 cycles of denaturation at 95 8C for 15 s and primer extension at 60 8C for 1 min. Data (Ct values) were analysed using the ABI Sequence Detector System software version 2.0, and the relative gene expression values, or fold changes, were analysed using the DataAssist Software v3.0 (Applied Biosystems) and normalised to the geometric mean Ct value of the five housekeeping genes. Candidate genes were prioritised based on the difference in fold-change gene mRNA expression in extravillous trophoblasts, cytotrophoblasts and side-population trophoblasts.
Real-time PCR
RNA derived from extravillous trophoblasts, villous cytotrophoblasts and side-population trophoblasts isolated from three placentae (7.4, 8.4 and 10 weeks of gestation) was converted into cDNA at equal concentrations using a Superscript III reverse transcriptase kit (Life Technologies) according to the manufacturer's instructions. cDNA was amplified using a custom pre-amp pool (Life Technologies) and the expression of genes of interest was determined using Custom Taqman Microfluidic Arrays (Life Technologies) according to the manufacturer's instructions. For LAMA2, TCN, COL6A1 and COL6A2, cDNA was not amplified and individual Taqman probes were used according to the manufacturer's instructions. Gene expression was normalised to the geometric mean of GAPDH and a further three housekeeping genes (GUSB, UBC, IPO8) specifically selected for their stability between extravillous trophoblasts, cytotrophoblasts and first trimester placental lysate samples using Taqman endogenous control gene array cards (data not shown). Statistical analysis of gene expression was done using Prism GraphPad software using a repeated measure ANOVA followed by a Bonferroni post-test to compare the differences between cell populations. P values !0.05 were considered statistically significant.
Immunohistochemical localisation of markers of sidepopulation trophoblasts in first trimester placentae
Genes that were specifically up-regulated in side-population trophoblasts were localised in sections from at least five first trimester placentae from 5.6 to 12.5 weeks of gestation. Paraffin-embedded sections were de-waxed in xylene and taken to water using an ethanol gradient. Antigen retrieval was undertaken in a 1 mM EDTA buffer (pH 8.0) in a pressure cooker and slides were then equilibrated in PBS for 15 min. For some antibodies, frozen sections fixed in ice-cold acetone for 10 min were used. Immunohistochemistry on all sections was performed as described previously (James et al. 2007 ) using a Zymed Histostain Plus Kit (Life Technologies), and staining was developed with AECC chromogen (Dako, Auckland, New Zealand). Primary antibodies reactive with collagen 6a3 (5 mg/ml, OAAF02910, Aviva Systems Biology) or laminin a2
(1 mg/ml, AB55409, Abcam) were used on paraffin embedded sections, while primary antibodies reactive with collagen 3a1 (0.5 mg/ml, AM20612PU-N, Acris Bioscience, Herford, Germany) or VCAM-1 (4 mg/ml, #555645, BD Biosciences, Auckland, New Zealand) were used on frozen sections. In each case serial sections were stained with antibodies reactive with cytokeratin 7 (0.4 mg/ml, M7018101-2, Dako). An irrelevant IgG1 control antibody (Life Technologies) was used as a negative control.
Results

A trophoblast Hoechst side-population exists within first trimester placental villi
Trophoblasts are the only epithelial cell type within the placenta, thereby cytokeratin 7 is frequently used to distinguish cells of the trophoblast lineage from mesenchymal cells of the villous core that are cytokeratin 7 negative but vimentin positive ( Fig. 1G ). We established a novel trypsin digestion protocol to obtain mononuclear cells from first trimester villi that were 95% cytokeratin 7 positive and vimentin negative (G2.3 S.E., nZ3 placentae, Fig. 1A ). When these cells were incubated with Hoechst 33342 and analysed by flow cytometry, a side-population characteristic of many adult stem cell populations was observed (Fig. 1B ). An average of 1.44% (G0.32 S.E., nZ30) of the cells were found within the side-population gate, and this side-population was enriched for trophoblasts with 98.5% of the cells expressing cytokeratin 7 and failing to express vimentin (G0.18 S.E., nZ3 placentae) (Fig. 1D ). b4 integrinpositive cytotrophoblasts were sorted from the main cell population outside the side-population gate (non-sidepopulation cells). Quantification of b4 integrin expression in side-population and non-side-population cells by FACS demonstrated that 8.85% (G6.7%) of sidepopulation trophoblasts were b4 integrin positive, whereas 87.03% (G4.9%, nZ4 placentae) of nonside-population cells were b4 integrin positive. Thus, b4 integrin expression is not a common feature of sidepopulation trophoblasts and may appear to be expressed as these cells begin to differentiate down the cytotrophoblast lineage to facilitate their adhesion to and migration along the basement membrane of the villus. Of sidepopulation cells, 99.5% did not express HLA-G, a marker of extravillous trophoblasts, indicating that these trophoblasts originated from within the placental villi (G0.2 S.E., nZ4 placentae) (Fig. 1E ). Along with their lack of vimentin expression, no isolated sidepopulation cells expressed class I HLA as determined by lack of reactivity with the W6/32 antibody that recognises a public determinant present in all class I HLA molecules (nZ3 placentae) (Fig. 1F) , demonstrating that these side-population cells are not mesenchymal cells. The low levels of mesenchymal cell contamination in side-population cells were confirmed by FACS, where (Fig. 1G) . The proportion of cells that constitute the side-population did not change significantly with gestational age between 6 and 12 weeks of gestation (Fig. 1C, nZ30 , PO0.05).
Global gene expression analysis suggests side-population trophoblasts are a separate population that express stem cell associated genes
To characterise side-population trophoblasts more extensively, the transcriptome of matched sets of HLA-G-positive extravillous trophoblasts, b4 integrin-positive cytotrophoblasts and side-population trophoblasts isolated from the same placenta (nZ5 placentae) were compared by Affymetrix PrimeView Array technology. Arrays were validated by comparing four individual genes of interest by real-time PCR (Fig. 2C , D, E and F).
Unsupervised hierarchical clustering of all transcripts using Ward's method revealed that four out five isolates of side-population trophoblasts formed a separate subpopulation that was more closely related to cytotrophoblasts than extravillous trophoblasts ( Fig. 2A) . Principal component analysis confirmed the relationships between these three populations (Fig. 2B) .
To identify genes that were uniquely up-or downregulated in side-population trophoblasts in comparison to more differentiated trophoblast populations, we determined which genes were common to both i) sidepopulation trophoblasts relative to cytotrophoblasts and ii) side-population trophoblasts relative to extravillous trophoblasts. Twenty-two genes were significantly (P!0.05) up-regulated Rtwofold in side-population trophoblasts in relation to both cytotrophoblasts and extravillous trophoblasts (Table 1) . However, no genes were significantly down-regulated Rtwofold in sidepopulation trophoblasts in comparison to both cytotrophoblasts and extravillous trophoblasts. GATHER analysis (http://gather.genome.duke.edu/) shows that the 22 genes specifically up-regulated in side-population trophoblasts are enriched for morphogenesis and organ development and the regulation of growth functions. As extracellular matrix proteins featured strongly in the 22 genes specifically up-regulated in side-population trophoblasts, this finding was followed up further. As COL6A3 was found to be specifically up-regulated in side-population trophoblasts, real-time PCR was conducted to evaluate the expression of the other two collagen six chains. This revealed that COL6A2 was significantly up-regulated in side-population trophoblasts in comparison to both extravillous trophoblasts (P!0.05) and cytotrophoblasts (P!0.005, nZ4), whereas COL6A1 showed a reduced expression in cytotrophoblasts in comparison to both extravillous trophoblasts (P!0.05) or side-population trophoblasts (P!0.005, nZ4) (data not shown). Furthermore, real-time PCR confirmed the specific up-regulation of LAMA2 (Fig. 2) and TNC (data not shown) by sidepopulation trophoblasts.
When side-population trophoblasts were compared only to cytotrophoblasts, to which they are the most closely related, 297 genes were significantly (FDRadjusted P!0.05) up-regulated Rtwofold and 22 genes were significantly down-regulated Rtwofold in sidepopulation trophoblasts. Pathway analysis using the GATHER tool revealed that these up-regulated genes were enriched for antigen processing and presentation, immune responses, metabolism, cell adhesion and transcription functions. When side-population trophoblasts were compared only to extravillous trophoblasts, 1557 genes were significantly up-regulated Rtwofold and 1434 genes were significantly down-regulated Rtwofold in side-population trophoblasts. GATHER pathway analysis revealed that these up-regulated genes were enriched for development, cell proliferation and cell cycle regulation and morphogenesis functions. A number of genes up-regulated in side-population trophoblasts have previously been identified as being important in trophectoderm lineage specification in both humans and mice (e.g., ELF5, TEAD4), while others have roles in maintaining other stem cell populations in an undifferentiated state (e.g., WNT5A, KLF4 and POU3F1) ( Table 2) . Supportive of the notion that side-population trophoblasts are committed to the trophoblast lineage, no significant differences in the inner cell mass markers POU5F1 (OCT4), SOX2 or NANOG were observed between side-population trophoblasts, villous cytotrophoblasts and extravillous trophoblasts. Side-population trophoblasts showed no significant difference in gene expression of the key mesenchymal stem cell markers 
Homeobox array analysis suggests side-population trophoblasts are a separate population of trophoblasts
Homeobox genes encode transcription factors that switch on gene cascades within cells and thus play an important role in cell differentiation during embryogenesis as well as controlling proliferation and differentiation in a number of stem cell populations (Murthi et al. 2011 ). Due to their potential importance in regulating stem cell differentiation within the placenta the expression of homeobox genes in side-population trophoblasts, villous cytotrophoblasts and extravillous trophoblasts (from three placentae) was compared using a Human HOX gene cDNA array. Of the 92 homeobox genes analysed in the array, nine were up-regulated more than 1.5-fold in side-population trophoblasts in comparison to both villous cytotrophoblast and extravillous trophoblast (Fig. 3A) . Of particular interest three genes -CDX1, CDX2 and HOXD9 -were up-regulated more than fivefold (Fig. 3A) . However, when CDX2 and HOXD9 were validated by real-time PCR in individual cell populations sorted from the same placenta (nZ3) only HOXD9 was shown to be significantly up-regulated in side-population cells in comparison to extravillous trophoblasts ( Fig. 3B and C) . No homeobox genes were down-regulated more than 1.5-fold in side-population trophoblasts in comparison to both cytotrophoblasts and extravillous trophoblasts.
Side-population trophoblasts differ from previously isolated trophoblast progenitor populations and embryonic stem cells
It has previously been reported that a TBPC population was isolated from the chorion of first trimester placentae (Genbacev et al. 2011) . To determine how similar our villus-derived side-population trophoblasts were to this previously published chorionic TBPC population, we reanalysed the data to compare genes that were significantly (P!0.05) up-or down-regulated more than twofold in side-population trophoblasts relative to cytotrophoblasts with genes up-or down-regulated more than twofold in TBPC relative to cytotrophoblasts. This demonstrated that only two out of 297 (0.75%) genes (COL3A1 and MYO1B) that were up-regulated more than twofold in side-population trophoblasts were also up-regulated in TBPC (Fig. 4A) . No genes were commonly down-regulated between these two groups (Fig. 4B ). This lack of similarity in gene expression suggests that our side-population trophoblasts are not the same cell population as the previously published TBPC.
To determine how similar our side-population trophoblasts were to hESCs, we reanalysed previously published microarray data of gene expression in hESC relative to cytotrophoblasts (Genbacev et al. 2011) to compare this to our microarray data of gene expression in side-population trophoblasts relative to cytotrophoblasts. This showed that 166 out of 297 (57%) genes that were expressed at levels more than twofold greater in side-population trophoblasts relative to cytotrophoblasts were also expressed more than twofold greater in hESC relative to cytotrophoblasts (Fig. 4C) . GATHER pathway analysis revealed that these genes were primarily enriched for antigen processing and presentation and immune response functions. In line with the ability of differentiated trophoblasts to evade the maternal immune system, this suggests that this difference may result from cytotrophoblasts down-regulating these genes as they differentiate from side-population trophoblasts or hESC. Four out of 22 (18%) genes that were expressed at levels more than twofold less in side population trophoblasts relative to cytotrophoblasts were also expressed more than twofold less in hESC relative to cytotrophoblasts (C2orf43, CDC25C, FGFR2 and RDM1) (Fig. 4D) . Because of the differing sizes of up-and down-regulated gene lists in the two datasets, we repeated this comparison using the top 200 up-and down-regulated genes only and found similar trends (data not shown). Taken together, these results indicate that side-population trophoblasts have some common features with hESC but are a distinct cell population. Takao et al. (2011) reported that a side-population could be isolated from the trophoblast cell line HTR8/ SVneo and from isolated villous cytotrophoblasts and that these side-population cells exclusively expressed interleukin-7 receptor (IL7R) and interleukin-1 receptor 2 (IL1R2). However, when our side-population trophoblasts were sorted onto Matrigel-coated wells and immunofluorescently labelled for IL7R or IL1R2, no expression of either of these markers was observed (Fig. 4E) . Furthermore, expression of IL7R and IL1R2 in sections of first trimester placental tissue appeared to be restricted to the mesenchymal core of placental villi (Fig. 4F) . Therefore, the differing methodology by which our side-population trophoblasts were obtained in this work has resulted in a side-population of trophoblasts that differs from those previously isolated by Takao et al.
Localisation of markers of the side-population trophoblasts in first trimester placenta
To localise side-population trophoblasts within placental villi, the expression of proteins encoding genes that were specifically up-regulated in side-population trophoblasts relative to cytotrophoblasts and extravillous trophoblasts was determined in first trimester placental sections by immunohistochemistry (Fig. 5) . Serial sections were labelled with antibodies reactive with cytokeratin 7 to identify trophoblasts (Fig. 5E, F, G and H) . Laminin a2 expression was observed at focal sites along the cytotrophoblast/mesenchymal boundary, as well as in occasional mesenchymal cells and blood vessel walls within the placental villi ( Fig. 5A and B, nZ5) . Similarly, collagen 6a3 was expressed in sporadic cells within the villus, within both the mesenchyme and the cytotrophoblast layer (Fig. 5C, nZ5) . Sporadic cells also stained strongly for collagen 6a3 underlying extravillous trophoblast outgrowth, while more diffuse staining was observed in extravillous trophoblasts (Fig. 5D ). At times, staining for both laminin a2 and collagen 6a3 could be observed in cells embedded in the stroma directly beneath the main cytotrophoblast layer, whereas at other times these cells appeared to form part of the cytotrophoblast monolayer directly beneath the syncytiotrophoblast. V-CAM-1 and collagen 3a1 were expressed throughout the mesenchymal core of the villi, as well as in cells likely to be trophoblasts directly adjacent to the syncytiotrophoblast ( Fig. 5I and J, nZ5). Although we cannot be absolutely certain of the specificity of these markers for sidepopulation cells, taken together, these results suggest that side-population trophoblasts are sparsely distributed throughout the cytotrophoblast layer, including cells underlying the extravillous trophoblast columns, and are in direct contact with the mesenchymal core of the villi.
Discussion
Our understanding of human placental development is significantly hampered by the lack of accurate models with which to study these early processes. To overcome this, we used the Hoechst side-population technique of isolating progenitor and stem cell populations (Redvers et al. 2006 , Samuel et al. 2009 , Shaharuddin et al. 2014 to isolate a novel population of trophoblasts from first trimester placentae and characterised these side-population trophoblasts with respect to more differentiated trophoblast populations. This revealed that side-population trophoblasts are a transcriptomically distinct population within the placenta and express a number of genes characteristic of other pluripotent stem cell populations and murine trophoblast stem cells. The Hoechst side-population technique has been used to identify adult stem cell populations in a range of organs including the heart, liver and kidney, as well as epithelial tissues with well-defined stem cell populations such as skin, colon and the corneal limbus (Redvers et al. 2006 , Samuel et al. 2009 , Shaharuddin et al. 2014 . In this work, we used this technique to isolate a population of trophoblasts from first trimester placental villi that are 98.5% pure. Side-population cells constituted 1.44% of the total live trophoblasts analysed, a proportion only slightly higher than the number of side-population cells previously derived from the colon (0.7%), an epithelial tissue known for high cellular turnover in a manner similar to the placenta (Samuel et al. 2009 ). Therefore, the proportion of side-population trophoblasts obtained in this work is in line with expectations for an organ undergoing rapid growth and turnover of its epithelium.
A number of genes of interest were up-regulated in side-population trophoblasts relative to villous cytotrophoblasts or extravillous trophoblasts, including those involved in the first stages of trophectoderm differentiation in the blastocyst that are thought to be critical gatekeeper genes for trophoblast stem cell function in the mouse and those involved in maintaining an undifferentiated/pluripotent phenotype in other human stem cell populations ( Table 2 ). The differences in expression of many of these genes were greater relative to extravillous trophoblasts than villous cytotrophoblasts. This not only reflects the fact that villous cytotrophoblasts are more closely related to sidepopulation trophoblasts but also is in agreement with previous data demonstrating the expression of genes thought to be restricted to murine trophoblast stem cells throughout the transit amplifying cytotrophoblast population in human placentae .
In the mouse placenta, Elf5, Cdx2, Eomes and Tcfap2 form a critical positive feedback loop defining murine trophoblast stem cell specification and reinforcement (Senner & Hemberger 2010) . Similarly, it has been proposed that in the human placenta ELF5 interacts with CDX2 and EOMES to establish a circuit of mutually interacting transcription factors, and an ELF5 and CDX2 positive population of putative trophoblast stem cells have been proposed to reside within the human placenta in the first trimester . However, it is evident both from molecular studies of bovine blastocysts (Berg et al. 2011) and anatomical studies highlighting the differences in implantation between mice and humans (James et al. 2012 ) that the regulatory networks governing trophectoderm specification and early trophoblast differentiation are likely to differ between murine models and those of other mammals. In our work, we observed a significant up-regulation of ELF5 in side-population cells relative to extravillous trophoblasts and in CDX2 expression relative to extravillous trophoblasts by homeobox array and microarray, although this could not be validated by real-time PCR. No significant difference in EOMES expression was observed, while TCFAP2 was not probed in the arrays. However, we did observe the up-regulation of 22 genes by side-population trophoblasts in comparison to both of the more mature trophoblast populations examined. Many of these 22 genes have previously been reported in stem cell niches in other tissues or play roles in embryonic development (Table 1) . Furthermore, the majority of these genes have not previously been investigated in the placenta, and understanding how they may contribute to the regulation of trophoblast stem cell maintenance or differentiation in the human placenta is an exciting prospect for future work.
The stem cell niche plays an important role in regulating stem cell function within a tissue. Such niches can often be characterised by key extracellular matrix proteins that interact with stem cell adhesion molecules to maintain pluripotency or drive differentiation. Therefore, it was of interest that in this work almost one-third of the 22 genes identified as being uniquely up-regulated in side-population trophoblasts were either extracellular matrix proteins or adhesion molecules that may comprise such a niche (collagen 3a1, collagen 6a3, decorin, laminin 2a, tenascin-C, thrombospondin-1, VCAM-1). Immunohistochemical localisation of some of these proteins in first trimester placentae indicated that markers of side-population trophoblasts are dispersed throughout the cytotrophoblast layer at the trophoblast/mesenchymal interface. Indeed, many epithelial stem cell populations are known to reside in close apposition to mesenchymal cells, and interactions between these cell types, including the ability of mesenchymal cells to control epithelial cell fate and the ability of epithelial cells to regulate mesenchymal cell organisation of tissue structure, are thought to play a key role in tissue morphogenesis (Birchmeier & Birchmeier 1993 , Blanpain et al. 2007 .
It was also of interest to observe collagen 6a3 positive cells in the multilayered trophoblast in the tips of anchoring villi from which extravillous trophoblast outgrowths arise. Our previous work has co-localised the extracellular matrix protein tenascin-C, which was specifically up-regulated by side-population trophoblasts in this work, to these sites of extravillous trophoblast outgrowth initiation (James et al. 2007) . Tenascin-C is found in many developing organs in the embryo, where it is most commonly expressed around budding or invaginating epithelia, but expression is largely lost in adult tissues where it is only evident in tissues bearing high tensile stress such as tendons and ligaments (Chiquet-Ehrismann et al. 2014) . Tenascin-C is an important component of stem cell niches in a number of tissues, including the cornea and skin, due to its ability to regulate stem cell maintenance and renewal (Chiquet-Ehrismann et al. 2014) . Functionally, tenascin-C can inhibit the activation of a5b1 integrin, one of the key integrins up-regulated during extravillous trophoblast differentiation (Huang et al. 2001 , Midwood & Schwarzbauer 2002 ) and, therefore, may play a particularly important role in maintaining a population of trophoblast stem cells in a pluripotent state at the site of extravillous trophoblast outgrowth initiation. Furthermore, the expression of markers of side-population trophoblasts in sporadic cells at both the sites of extravillous trophoblast outgrowth initiation and throughout the cytotrophoblast monolayer underlying the syncytiotrophoblast suggests that side-population trophoblasts may be capable of contributing to both of the major trophoblast lineages in the mature human placenta.
A handful of other researchers have previously attempted to isolate trophoblast progenitor populations from the placenta. Spitalieri et al. (2009) identified a population of cells within the cytotrophoblast layer of placental villi that express stem cell markers, but these cells gradually differentiate into fibroblasts and epithelial-like cells in culture rather than into more differentiated trophoblast lineages. More recently, Genbacev et al. (2011) isolated a population of continuously self-replicating TBPCs from the chorionic membrane of first trimester placentae. Our side-population trophoblasts show a very different gene expression profile compared to TBPC (Fig. 4) , which up-regulate genes involved in neuronal development, stem cell pluripotency, integrin signalling and thrombin signalling (Genbacev et al. 2011) . It is possible this may be a result of differences in the gestational age of the placentae from which the reference cytotrophoblast population was isolated in the two studies. Alternatively, in our study, trophoblasts were extracted using entirely different digestion methods and from placental villi rather than the chorionic membrane. We believe that these data indicate that we have isolated a novel population that differs significantly from TBPC isolated from the chorionic membrane described by Genbacev et al.
Due to the lack of available human trophoblast stem cell models, researchers have attempted to study the early human trophoblast differentiation pathways by employing a model in which hESC can be induced to differentiate into trophoblast-like cells when treated with BMP4 (Golos et al. 2013 ). This produces a heterogeneous population of trophoblast in which both multinucleated syncytium and HLA-G positive extravillous trophoblast-like cells can be observed (Golos et al. 2013) . However, one of the issues surrounding this model is whether hESCs are truly being differentiated into trophoblast stem cell-like cells or whether they are forming a mesodermal cell lineage (Roberts et al. 2014) . The catch-22 with this issue is that without an existing model of human trophoblast stem cells, we are unable to define what the molecular signature of true human trophoblast stem cell is. The isolation and molecular characterisation of side-population trophoblasts in this work may provide a step toward resolving this problem. However, to conclusively prove that side-population trophoblasts are true trophoblast stem cells and to be able to employ these stem cells as a useful model with which to understand trophoblast differentiation in early pregnancy, we must develop methods by which to differentiate them into the terminally differentiated trophoblast lineages: cytotrophoblast, syncytiotrophoblast and extravillous trophoblast. Confirmation that these side-population trophoblasts are true stem cells will require that they can be differentiated into transient trophoblast populations that appear at implantation, the primitive cytotrophoblast and primitive syncytium, which are functionally distinct from the mature cytotrophoblast and syncytiotrophoblast populations found during most of gestation.
In conclusion, we have isolated a novel sidepopulation of trophoblasts from first trimester human placental villi and demonstrated that these cells are a transcriptomically distinct population of trophoblasts that express some markers characteristic of progenitor/ stem cells. Future work to characterise the differentiation potential of these cells may provide a crucial link in our understanding of how placental organogenesis and trophoblast differentiation is regulated in early pregnancy and opens the door for future work to understand the factors regulating these processes and how they may be aberrant in pregnancy disorders.
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